IT - EN
Pharmaceutical Operations

Pharmaceutical OperationsR & DPipeline

NAME ORIGINATOR INDICATION DEVELOPMENT STATUS
REAGILA® Gedeon Richter Schizophrenia Approved in EU
Launch phase
methadone   Treatment of cancer-related pain in cases of resistance or intolerance to opioids Filed in France
CARBAGLU® Recordati Hyperammonaemia due to NAGS deficiency and to the main organic acidemias Development of new formulations in EU and USA
Pre-filing in the USA for the organic acidemias indication
REC 0551 Recordati/Meyer Hospital (Florence) Retinopathy of Prematurity (ROP) Phase II
LYNOVEX® NovaBiotics Acute infectious exacerbations associated with cystic fibrosis Phase II
REC 0438 Recordati/UFPeptides Neurogenic detrusor overactivity in paediatric spina bifida patients
Proof of concept trial planning in EU
REC 0559 Recordati/Mime Tech Neurotrophic keratitis Formulation development
Clinical development planning
REC 0545 Recordati/AP-HP Acute decompensation episodes in MSUD Formulation development
Clinical development planning